Li, W.; Zwierenga, F.; Andini, K.D.; Bucher, J.M.; Scherpen, F.; Hiltermann, T.J.N.; Groen, H.J.M.; van der Wekken, A.J.; Kok, K.; Berg, A.v.d.
Presence of On-Target Resistant Mutation in Pre-Treatment Samples of ALK Fusion Gene Positive Lung Cancer Patients. Cancers 2025, 17, 1090.
https://doi.org/10.3390/cancers17071090
AMA Style
Li W, Zwierenga F, Andini KD, Bucher JM, Scherpen F, Hiltermann TJN, Groen HJM, van der Wekken AJ, Kok K, Berg Avd.
Presence of On-Target Resistant Mutation in Pre-Treatment Samples of ALK Fusion Gene Positive Lung Cancer Patients. Cancers. 2025; 17(7):1090.
https://doi.org/10.3390/cancers17071090
Chicago/Turabian Style
Li, Weiting, Fenneke Zwierenga, Katarina D. Andini, Justyna M. Bucher, Frank Scherpen, T. Jeroen N. Hiltermann, Harry J. M. Groen, Anthonie J. van der Wekken, Klaas Kok, and Anke van den Berg.
2025. "Presence of On-Target Resistant Mutation in Pre-Treatment Samples of ALK Fusion Gene Positive Lung Cancer Patients" Cancers 17, no. 7: 1090.
https://doi.org/10.3390/cancers17071090
APA Style
Li, W., Zwierenga, F., Andini, K. D., Bucher, J. M., Scherpen, F., Hiltermann, T. J. N., Groen, H. J. M., van der Wekken, A. J., Kok, K., & Berg, A. v. d.
(2025). Presence of On-Target Resistant Mutation in Pre-Treatment Samples of ALK Fusion Gene Positive Lung Cancer Patients. Cancers, 17(7), 1090.
https://doi.org/10.3390/cancers17071090
